Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

Cardiovascular diseases claim a number of lives globally; many of which are preventable.
With the increase in diets that consist of high saturated fat, salt, and sugar, people often …

Decorin (DCN) is the best characterized member of the extracellular small leucine‐rich
proteoglycan family present in connective tissues, typically in association with or …

The challenges and difficulties associated with conventional drug delivery systems have led
to the emergence of novel, advanced targeted drug delivery systems. Therapeutic drug …

Pulmonary hypertension (PH) is a pathophysiologic disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

Highlights•Nanomedicine has emerged as a field with great opportunities to improve
treatment strategies.•Pulmonary arterial hypertension (PAH) is a serious and incurable …

Introduction: Pulmonary arterial hypertension (PAH) is a progressive disease characterized
by remodeling of small pulmonary arteries leading to increased pulmonary arterial pressure …

The tumor microenvironment plays a determining role in cancer development through a
plethora of interactions between the extracellular matrix and tumor cells. Decorin is a …

We describe the use of bioactive peptides to drive liposomal drugs on target receptors
overexpressed in cancer cells. A detailed description for several targeting liposomes …

Extracellular matrix (ECM) molecules play important roles in regulating processes such as
cell proliferation, migration, differentiation and survival. Decorin is a proteoglycan that binds …